Other Notices

2018-01-312018-01-122018-01-11TSO (The Stationery Office), St Crispins, Duke Street, Norwich, NR3 1PD, 01603 622211, customer.services@tso.co.uk29456348015

Department of Health



The Department of Health has made a Statutory Rule entitled The Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2018 (SR 2018 No. 4) which comes into operation on 31st January 2018.

These Regulations amend the Misuse of Drugs Regulations (Northern Ireland) 2002 (S.R. 2002 No.1) (“the Regulations”). The Schedule of the Regulations in which a controlled drug is placed affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed and dictates the record keeping, labelling and destruction requirements in relation to that drug.

Regulation 3 adds a synthetic opioid (known as U-47,700), several methylphenidate related materials, a number of cannabinoids, methiopropamine or “MPA”, and a number of designer benzodiazepines to Schedule 1 to the Regulations. The controlled drugs placed in Schedule 1 to the Regulations are subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27.

Regulation 4 adds an anabolic steroid, known as Dienedione (estra-4, 9-diene-3,17-dione), to Part 2 of Schedule 4 to the Regulations Controlled drugs placed in Part 2 of Schedule 4 are exempt from the prohibition on importation exportation and from the prohibition on possession when in the form of a medicinal product.

This Rule may be purchased from the Stationery Office at www.tsoshop.co.uk or by contacting TSO Customer Services on 0333 202 5070, or viewed online at www.legislation.gov.uk/nisr